A Systematic Review of MiRNA and CfDNA As Potential Biomarkers for Liquid Biopsy in Myocarditis and Inflammatory Dilated Cardiomyopathy

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2022 Oct 27

PMID 36291684

Authors

Piotr Lewandowski

Marcin Golawski

Maciej Baron

Edyta Reichman-Warmusz

Romuald Wojnicz

Affiliations

Soon will be listed here.

Abstract

Myocarditis and inflammatory dilated cardiomyopathy are cardiac diseases leading to heart failure. Liquid biopsy is a concept of replacing traditional biopsy with specialized blood tests. The study aim was to summarize and assess the usefulness of microRNAs and circulating free DNA as biomarkers of myocardial inflammation. For this systematic review, we searched Scopus, Embase, Web of Science, and PubMed. All studies measuring microRNAs in serum/plasma/cardiac tissue or circulating free DNA during myocarditis and non-ischemic dilated cardiomyopathy in humans in which healthy subjects or another cardiac disease served as a comparator were included. Data were extracted and miRNAs were screened and assessed using a scale created in-house. Then, highly graded miRNAs were assessed for usability as liquid biopsy biomarkers. Of 1185 records identified, 56 were eligible and 187 miRNAs were found. We did not identify any studies measuring circulating free DNA. In total, 24 of the screened miRNAs were included in the final assessment, 3 of which were selected as the best and 3 as potential candidates. We were not able to assess the risk of bias and the final inclusion decision was made by consensus. Serum levels of three miRNAs-miR-Chr8:96, miR-155, and miR-206-are the best candidates for myocardial inflammation liquid biopsy panel. Further studies are necessary to prove their role, specificity, and sensitivity.

Citing Articles

The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis.

Mlynarska E, Badura K, Kurcinski S, Sinkowska J, Jakubowska P, Rysz J Int J Mol Sci. 2024; 25(20).

PMID: 39456716 PMC: 11507602. DOI: 10.3390/ijms252010933.

Artificial intelligence and myocarditis-a systematic review of current applications.

Lajczak P, Jozwik K Heart Fail Rev. 2024; 29(6):1217-1234.

PMID: 39138803 PMC: 11455665. DOI: 10.1007/s10741-024-10431-9.

The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins.

Felekkis K, Papaneophytou C Int J Mol Sci. 2024; 25(6).

PMID: 38542382 PMC: 10969827. DOI: 10.3390/ijms25063403.

Biomarkers in Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Updated Review of the Literature.

Crisci G, Bobbio E, Gentile P, Bromage D, Bollano E, Ferone E J Clin Med. 2023; 12(23).

PMID: 38068265 PMC: 10706911. DOI: 10.3390/jcm12237214.

MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy.

Aleshcheva G, Baumeier C, Harms D, Bock C, Escher F, Schultheiss H ESC Heart Fail. 2023; 10(6):3410-3418.

PMID: 37679968 PMC: 10682862. DOI: 10.1002/ehf2.14523.

References

Kuehl U, Lassner D, Gast M, Stroux A, Rohde M, Siegismund C . Differential Cardiac MicroRNA Expression Predicts the Clinical Course in Human Enterovirus Cardiomyopathy. Circ Heart Fail. 2015; 8(3):605-18. DOI: 10.1161/CIRCHEARTFAILURE.114.001475. View

Woulfe K, Siomos A, Nguyen H, SooHoo M, Galambos C, Stauffer B . Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy. J Card Fail. 2016; 23(4):314-324. PMC: 5380509. DOI: 10.1016/j.cardfail.2016.11.006. View

Ishiguro T, Hayashi M, Fujiwara W, Okumura S, Yoshinaga M, Yamada R . Circulating miR-489 as a potential new biomarker for idiopathic dilated cardiomyopathy. Fujita Med J. 2022; 7(1):18-22. PMC: 8749486. DOI: 10.20407/fmj.2020-001. View

Gumus G, Giray D, Bobusoglu O, Tamer L, Karpuz D, Hallioglu O . MicroRNA values in children with rheumatic carditis: a preliminary study. Rheumatol Int. 2018; 38(7):1199-1205. DOI: 10.1007/s00296-018-4069-2. View

Taylor S, Laperriere G, Germain H . Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data. Sci Rep. 2017; 7(1):2409. PMC: 5445070. DOI: 10.1038/s41598-017-02217-x. View

Nie X, He M, Wang J, Chen P, Wang F, Lai J . Circulating miR-4763-3p Is a Novel Potential Biomarker Candidate for Human Adult Fulminant Myocarditis. Mol Ther Methods Clin Dev. 2020; 17:1079-1087. PMC: 7248292. DOI: 10.1016/j.omtm.2020.05.005. View

McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With.... Eur Heart J. 2021; 42(48):4901. DOI: 10.1093/eurheartj/ehab670. View

Chen Z, Liu H, Zhang J, Zhang S, Zhao L, Liang W . Upregulated microRNA-214 enhances cardiac injury by targeting ITCH during coxsackievirus infection. Mol Med Rep. 2015; 12(1):1258-64. DOI: 10.3892/mmr.2015.3539. View

Wang H, Chen F, Tong J, Li Y, Cai J, Wang Y . Circulating microRNAs as novel biomarkers for dilated cardiomyopathy. Cardiol J. 2016; 24(1):65-73. DOI: 10.5603/CJ.a2016.0097. View

10.

Onrat S, Onrat E, Ercan Onay E, Yalim Z, Avsar A . The Genetic Determination of the Differentiation Between Ischemic Dilated Cardiomyopathy and Idiopathic Dilated Cardiomyopathy. Genet Test Mol Biomarkers. 2018; 22(11):644-651. DOI: 10.1089/gtmb.2018.0188. View

11.

Aleshcheva G, Pietsch H, Escher F, Schultheiss H . MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies. ESC Heart Fail. 2020; 8(1):408-422. PMC: 7835602. DOI: 10.1002/ehf2.13090. View

12.

Fan K, Zhang H, Shen J, Zhang Q, Li X . Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart J. 2013; 65(1):12-6. PMC: 3860780. DOI: 10.1016/j.ihj.2012.12.022. View

13.

Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

14.

Wang D, Li T, Cui H, Zhang Y . Analysis of the Indicating Value of Cardiac Troponin I, Tumor Necrosis Factor-α, Interleukin-18, Mir-1 and Mir-146b for Viral Myocarditis among Children. Cell Physiol Biochem. 2016; 40(6):1325-1333. DOI: 10.1159/000453185. View

15.

Chen J, He J, Zhou R, Zheng N . [Expression and Significance of Circulating microRNA-29b in Adult Fulminant Myocarditis]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022; 44(1):102-109. DOI: 10.3881/j.issn.1000-503X.14043. View

16.

Bao J, Lin L . MiR-155 and miR-148a reduce cardiac injury by inhibiting NF-κB pathway during acute viral myocarditis. Eur Rev Med Pharmacol Sci. 2014; 18(16):2349-56. View

17.

Yan M, Wang J, Wang S, Zhang Y, Liu L, Zhao H . Expression Levels of MicroRNA-146b and Anti-Cardiac Troponin I in Serum of Children with Viral Myocarditis and Their Clinical Significance. Iran J Public Health. 2021; 50(3):510-519. PMC: 8214613. DOI: 10.18502/ijph.v50i3.5592. View

18.

Jiao M, You H, Yang X, Yuan H, Li Y, Liu W . Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy. Sci Rep. 2018; 8(1):724. PMC: 5768721. DOI: 10.1038/s41598-017-19138-4. View

19.

Baan J, Varga Z, Leszek P, Kusmierczyk M, Baranyai T, Dux L . Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study. J Transl Med. 2015; 13:1. PMC: 4301667. DOI: 10.1186/s12967-014-0365-0. View

20.

Tao L, Yang L, Huang X, Hua F, Yang X . Reconstruction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA Reveal Functional lncRNAs in Dilated Cardiomyopathy. Front Genet. 2019; 10:1149. PMC: 6873784. DOI: 10.3389/fgene.2019.01149. View